|
1. Semnani S, Besharat S, Arabali A, Kestkar AA, Roshandel Gh, Abdolahi N, et al. Relation between drinking water hardness and the incidence of esophageal and gastric cancers. J Gorgan Univ Med Sci 2009; 11:76-80. 2. IW CD, Jaia CJ. Gastric cancer epidemiology: current trend and future direction. Hygiene 2023; 3:256-68. doi:10.3390/hygiene3030019. 3. Eom SS, Choi W, Eom BW, Park SH, Kim SJ, Kim YI, et al. A Comprehensive and Comparative Review of Global Gastric Cancer Treatment Guidelines. J Gastric Cancer 2022; 22:3-23. doi: 10.5230/jgc.2022.22. e10. 4. Wang F, Li T, Zhang B, Li H, Wu Q, Yang L, et al. MicroRNA- 19a/b regulates multidrug resistance in human gastric cancer cells by targeting PTEN. Biochem Biophys Res Commun 2013; 434:688-94. doi: 10.1016/j.bbrc.2013.04.010. 5. Mocan L. Surgical Management of Gastric Cancer: A Systematic Review. J Clin Med 2021; 10:2557. doi: 10.3390/jcm10122557. 6. Lang SA, Gaumann A, Koehl GE, Seidel U, Bataille F, Klein D, et al. Mammalian target of rapamycin is activated in human gastric cancer and serves as a target for therapy in an experimental model. Int J Cancer 2007; 120:1803-10. doi: 10.1002/ijc.22442. 7. Guan WL, He Y, Xu RH. Gastric cancer treatment: recent progress and future perspectives. J Hematol Oncol 2023; 16:57. doi: 10.1186/s13045-023-01451-3. 8. Panda SK, Sahoo PK, Agarwala SK, Houghton TT, Chandrapattan PP, Sankar KV, et al. Evolution of treatment in gastric cancer- a systematic review. J Egypt Natl Canc Inst 2022; 34:12. doi: 10.1186/s43046-022-00114-7. 9. Wong H, Yau T. Molecular targeted therapies in advanced gastric cancer: does tumor histology matter? Therap Adv Gastroenterol 2013; 6:15-31. doi: 10.1177/1756283X12453636. 10. Yaghoobi H, Bandeh poor M, Kazemi B. 2016.Application of bacteria in the treatment of cancer. New Cell Biotech Mol 2016; 26:96-100[Persian]. 11. Slizewska K, Kopec PM, Slizewska W. The roles of probiotics in cancer prevention. Cancers 2021; 13: 1-22. doi: 10.3390/cancers13010020. 12. Kumar A, Pramanik J, Goyal N, Chauhan D, Sivamaruthi BS, Prajapati BG, et al. Gut Microbiota in Anxiety and Depression: Unveiling the Relationships and Management Options. Pharmaceuticals 2023;16:565. doi: 10.3390/ph16040565. 13. Faghfoori Z, Faghfoori MH, Saber A, Izadi A, Yari Khosroushahi A. Anticancer effects of bifidobacteria on colon cancer cell lines. Cancer Cell Int 2021; 21:258. doi: 10.1186/s12935-021-01971-3. 14. Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin 2023; 73:17-48. doi: 10.3322/caac.21763. 15. Araghi M, Soerjomataram I, Jenkins M, Brierley J, Morris E, Bray F, et al. Global trends in colorectal cancer mortality: projections to the year 2035. Int J Cancer 2019; 144:2992-3000. doi: 10.1002/ijc.32055. 16. Brenner AT, Dougherty M, Reuland DS. Colorectal cancer screening in average risk patients. Med Clin North Am 2017; 101:755-67. doi: 10.1016/j.mcna.2017.03.007. 17. Asadollahi P, Ghanavati R, Rouhani M, Razavi S, Esghaei M, Talebi M. Anticancer efects of Bifdobacterium species in colon cancer cells and a mouse model of carcinogenesis. PloS One 2020; 15:1-18. doi: 10.1371/journal.pone.0232930. 18. Nowak A, Paliwoda A, Błasiak J. Anti-proliferative, pro-apoptotic and antioxidative activity of Lactobacillus and Bifdobacterium strains: A review of mechanisms and therapeutic perspectives. Crit Rev Food Sci Nutr 2019;59:3456-67. doi: 10.1080/10408398.2018.1494539. 19. Tiptiri-Kourpeti A, Spyridopoulou K, Santarmaki V, Aindelis G, Tompoulidou E, Lamprianidou EE, et al. Lactobacillus casei exerts anti-proliferative efects accompanied by apoptotic cell death and up-regulation of TRAIL in colon carcinoma cells. PLoS One 2016; 11:e0147960. doi: 10.1371/journal.pone.0147960. 20. Fahmy CA, Gamal-Eldeen AM, El-Hussieny EA, Raafat BM, Mehanna NS, Talaat RM, et al. Bifdobacterium longum suppresses murine colorectal cancer through the modulation of oncomirs and tumor suppressor mirnas. Nutr Cancer 2019; 71:688-700. doi: 10.1080/01635581.2019.1577984. 21. Miller LE, Lehtoranta L, Lehtinen MJ. 2017. The efect of Bifdobacterium animalis ssp. lactis HN019 on cellular immune function in healthy elderly subjects: systematic review and meta-analysis. Nutrients 2017; 9:191. doi: 10.3390/nu9030191. 22. Zhong L, Zhang X, Covasa M. Emerging roles of lactic acid bacteria in protection against colorectal cancer. World J Gastroenterol 2014; 20:7878-86. doi: 10.3748/wjg.v20.i24.7878. 23. Zarei L, Abtahim M, Karaje Daghi A, Ismaili H. Direct effect of bifidobacterium cell wall extract on the proliferation of K562 cancer cell line. J Fasa Univ Med Sci 2016; 7:21-27. 24. Kato S, Hamouda N, Kano Y, Oikawa Y, Tanaka Y, Matsumoto K, et al . Probiotic Bifidobacterium bifidum G9-1 attenuates 5-fluorouracil-induced intestinal mucositis in mice via suppression of dysbiosis-related secondary inflammatory responses. Clin Exp Pharmacol Physiol 2017;44:1017-25. doi: 10.1111/1440-1681.12792. 25. Wei H, Chen L, Lian G, Yang J, Li F, Zou Y, et al. Antitumor mechanisms of bifidobacteria(review). Oncol Lett 2018; 16:3-8. doi: 10.3892/ol.2018.8692.
|
